KETAMINE PATCH
The ketamine patch has been in development for several years and is designed to deliver controlled, sustained analgesia for both acute postoperative pain and chronic pain conditions, enabling adoption in hospital, outpatient, and home-care settings. By leveraging the established safety profile, clinical experience, and FDA approval of its ketamine ANDA, PharmaTher aims to accelerate development of the patch as a scalable, patient-friendly, non-opioid solution that directly addresses this national public health crisis.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."
Connect With Us
PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario Canada
M5C 1P1
82 Richmond Street East
Toronto, Ontario Canada
M5C 1P1
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."
© COPYRIGHT 2025. PharmaTher Holdings Ltd. ALL RIGHTS RESERVED.